Akira Endo | |
|---|---|
遠藤章 | |
&sq=Envato&lang=en&file=File:Akira_Endo_cropped_3_Akira_Endo_201111.jpg) | |
| Born | 14 November 1933 |
| Died | 5 June 2024 (aged 90) |
| Alma mater | Tohoku University, |
| Known for | Discovering the first statin (HMG-CoA reductase inhibitor), paving the way for statin drug development |
| Awards | Heinrich Wieland Prize (1987) Japan Prize (2006) Massry Prize (2006) Lasker Award (2008) National Inventors Hall of Fame 2012) Canada Gairdner International Award (2017) |
| Scientific career | |
| Fields | Biochemistry |
| Institutions | Sankyo Co., Tokyo University of Agriculture and Technology |
Akira Endo (遠藤 章, Endō Akira, 14 November 1933 – 5 June 2024) was a Japanese biochemist whose research into the relationship between fungi and cholesterol biosynthesis led to the development of statin drugs, which are some of the best-selling pharmaceuticals in history.
Endo received the Japan Prize in 2006,[1] the Lasker-DeBakey Clinical Medical Research Award in 2008,[2] the Canada Gairdner International Award in 2017.
- ^ The Science and Technology Foundation of Japan. Japan Prize official release Archived 10 January 2007 at the Wayback Machine, accessed 21 June 2006
- ^ Lasker~DeBakey Clinical Medical Research Award, 2008: Akira Endo